Tufton Capital Management Merck & Co., Inc. Transaction History
Tufton Capital Management
- $518 Million
- Q1 2025
A detailed history of Tufton Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tufton Capital Management holds 104,797 shares of MRK stock, worth $8.17 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
104,797
Previous 104,684
0.11%
Holding current value
$8.17 Million
Previous $10.4 Million
9.67%
% of portfolio
1.82%
Previous 1.97%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,890Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.4 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.37 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.65 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $198B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...